NCT01624779

Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury

The Effect of Intrathecal Transplantation of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Patients With Spinal Cord Injury, Phase I Clinical Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Bukwang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The effect of intrathecal transplantation of autologous adipose tissue derived mesenchymal stem cells in the patients with spinal cord injury, Phase I Clinical study.

Conditions

• Spinal Cord Injury

Interventions

Type	Name	Description
DRUG	autologous adipose tissue derived mesenchymal stem cells	autologous adipose tissue derived mesenchymal stem cells 9x107cells / 3mL Day 1 and Month 1\&2

Timeline

• Start date: 2012-04-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2012-06-21
• Last updated: 2015-02-13

Locations

1 site across 1 country: South Korea